Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Keith R. Leonard

At a glance: Keith R. Leonard is Director at Arcutis Biotherapeutics (ARQT). Their latest SEC Form 4, filed Mar 4, 2026, reported a sale of $997K. On file: 0 purchase lines ($0) and 1 sale line ($997K).

Disclosed holdings: about $589K of ARQT stock: 22,123 shares reported on their latest Form 4 (filed Mar 4, 2026), valued at the Nov 20, 2026 close of $26.64. This counts only ARQT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Arcutis Biotherapeutics, Inc. (ARQT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $997K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 4SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 39,27222,123 held (−64%) $25.39 $997K +4.9%
  • Sell

    Director Keith R Leonard sold $997K of ARQT at $25.39 — cuts the stake by 64%; pre-scheduled 10b5-1 plan sale.

Follow Keith R. Leonard

Get one email when Keith R. Leonard files a new purchase or sale. Free.

At most one email a day about Keith R. Leonard, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.